42-jähriger Patient mit bilateralem Visusverlust und hypertensiver Entgleisung

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Der Internist

• Publication date

  2008-04-23

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s00108-008-2123-yPMID 18427761
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gemcitabine-associated thrombotic thrombocytopenic purpura.

  2007cited by this paper
• Clinical practice. Thrombotic thrombocytopenic purpura.

  2006cited by this paper
• Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome

  2006cited by this paper
• Hemolytic uremic syndrome.

  2005cited by this paper
• Hemolytic-uremic syndrome associated with gemcitabine: a case report and review of literature.

  2005cited by this paper
• von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience.

  2004cited by this paper
• Gemcitabine‐associated thrombotic microangiopathy

  2004cited by this paper
• Drug‐induced Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome: A Concise Review

  2004cited by this paper
• Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation

  2003cited by this paper
• [44-year-old patient with thrombocytopenia, multiple organ failure and disseminated intravascular coagulation caused by drug poisoning with paracetamol, metamizole, benzodiazepines and alcohol in attempted suicide].

  2001cited by this paper
• Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases.

  2001cited by this paper
• 44-jährige Patientin mit Thrombozytopenie, Multiorganversagen und disseminierter intravasaler Gerinnung Infolge einer Tablettenintoxikation mit Paracetamol, Metamizol, Benzodiazepinen und Alkohol in suizidaler Absicht

  2001cited by this paper
• Nierenversagen, Thrombozytopenie und hämolytische Anämie bei einem 36-jährigen Patienten

  2001cited by this paper
• [Renal failure, thrombocytopenia and hemolytic anemia in a 36-year-old patient].

  2001cited by this paper
• Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura‐hemolytic‐uremic syndrome

  2000cited by this paper
• How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.

  2000cited by this paper
• Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine.

  1999cited by this paper
• Effectiveness of therapeutic plasma exchange in the 1996 Lanarkshire Escherichia coli O157:H7 outbreak.

  1999cited by this paper
• Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.

  1998cited by this paper
• von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

  1998cited by this paper
• Comparison of Plasma Exchange With Plasma Infusion in the Treatment of Thrombotic Thrombocytopenia Purpura

  1992cited by this paper
• Inherited hemolytic uremic syndrome in adults.

  1992cited by this paper
• Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group.

  1991cited by this paper
• HUS and TTP: Variable expression of a single entity

  1987cited by this paper
• HUS and TTP: variable expression of a single entity.

  1987cited by this paper
• Renal involvement in patients with thrombotic thrombocytopenic purpura.

  1986cited by this paper
• Mitomycin-induced hemolytic uremic kidney. An experimental model in the rat.

  1985cited by this paper
• [Hemolytic-uremic syndrome in children and arterial hypertension].

  1981cited by this paper

• Gemcitabine: vascular toxicity and prothrombotic potential.

  2008cites this paper
• Gemcitabine: vascular toxicity and prothrombotic potential

  2008cites this paper